Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 856

1.

New Zealand white rabbit: a novel model for prolapse mesh implantation via a lumbar colpopexy.

Knight KM, Artsen AM, Routzong MR, King GE, Abramowitch SD, Moalli PA.

Int Urogynecol J. 2019 Aug 15. doi: 10.1007/s00192-019-04071-z. [Epub ahead of print]

PMID:
31418044
2.

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model.

Zoine JT, Knight KA, Fleischer LC, Sutton KS, Goldsmith KC, Doering CB, Spencer HT.

Oncoimmunology. 2019 May 27;8(8):1593804. doi: 10.1080/2162402X.2019.1593804. eCollection 2019.

3.

Reproductive (In)justice - Two Patients with Avoidable Poor Reproductive Outcomes.

Knight KR, Duncan LG, Szilvasi M, Premkumar A, Matache M, Jackson A.

N Engl J Med. 2019 Aug 15;381(7):593-596. doi: 10.1056/NEJMp1907437. No abstract available.

PMID:
31412176
4.

Vulnerable Patients' Psychosocial Experiences in a Group-Based, Integrative Pain Management Program.

Bruns EB, Befus D, Wismer B, Knight K, Adler SR, Leonoudakis-Watts K, Thompson-Lastad A, Chao MT.

J Altern Complement Med. 2019 Jul;25(7):719-726. doi: 10.1089/acm.2019.0074.

PMID:
31314560
5.

Author Correction: The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2019 Jul 4;51(7):71. doi: 10.1038/s12276-019-0252-0.

PMID:
31270317
6.

Structure and physical properties of SeCo1-x Mn x O3.

Ridley CJ, Knight KS, Wilson CW, Smith RI, Bull CL.

J Phys Condens Matter. 2019 Oct 2;31(39):395402. doi: 10.1088/1361-648X/ab2db9. Epub 2019 Jun 28.

PMID:
31252418
7.

High-Pressure Study of the Elpasolite Perovskite La2NiMnO6.

Ridley CJ, Daisenberger D, Wilson CW, Stenning GBG, Sankar G, Knight KS, Tucker MG, Smith RI, Bull CL.

Inorg Chem. 2019 Jul 15;58(14):9016-9027. doi: 10.1021/acs.inorgchem.9b00404. Epub 2019 Jun 26.

PMID:
31241907
8.

The role of physical and psychological health problems in the drug use treatment process.

Joe GW, Lehman WEK, Rowan GA, Knight K, Flynn PM.

J Subst Abuse Treat. 2019 Jul;102:23-32. doi: 10.1016/j.jsat.2019.03.011. Epub 2019 Mar 30.

PMID:
31202285
9.

Who is the patient? Tensions between advance care planning and shared decision-making.

Knight K.

J Eval Clin Pract. 2019 Jun 7. doi: 10.1111/jep.13149. [Epub ahead of print]

PMID:
31172655
10.

Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.

Freyer DR, Brock P, Knight K, Reaman G, Cabral S, Robinson PD, Sung L.

Lancet Child Adolesc Health. 2019 Aug;3(8):578-584. doi: 10.1016/S2352-4642(19)30115-4. Epub 2019 May 31. Review.

PMID:
31160205
11.

Impact of polypropylene prolapse mesh on vaginal smooth muscle in rhesus macaque.

Shaffer RM, Liang R, Knight K, Carter-Brooks CM, Abramowitch S, Moalli PA.

Am J Obstet Gynecol. 2019 May 16. pii: S0002-9378(19)30666-0. doi: 10.1016/j.ajog.2019.05.008. [Epub ahead of print]

PMID:
31102587
12.

Sources and Impact of Time Pressure on Opioid Management in the Safety-Net.

Satterwhite S, Knight KR, Miaskowski C, Chang JS, Ceasar R, Zamora K, Kushel M.

J Am Board Fam Med. 2019 May-Jun;32(3):375-382. doi: 10.3122/jabfm.2019.03.180306.

13.

Treatment Retention Satisfaction, and Therapeutic Progress for Justice-Involved Individuals Referred to Community-Based Medication-Assisted Treatment.

Yang Y, Gray J, Joe GW, Flynn PM, Knight K.

Subst Use Misuse. 2019;54(9):1461-1474. doi: 10.1080/10826084.2019.1586949. Epub 2019 Apr 29.

PMID:
31030611
14.

Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia.

DiPrete BL, Pence BW, Golin CE, Knight K, Flynn PM, Carda-Auten J, Groves JS, Powers KA, White BL, Napravnik S, Wohl DA.

AIDS Behav. 2019 Apr 8. doi: 10.1007/s10461-019-02488-7. [Epub ahead of print]

PMID:
30963321
15.

So long Raul and welcome Trish.

Knight K.

J Exp Biol. 2019 Mar 28;222(Pt 6). pii: jeb202952. doi: 10.1242/jeb.202952. No abstract available.

PMID:
30923074
16.

Crystal structures and electronic properties in 3d transition metal doped SrRuO3.

Qasim I, Blanchard PER, Knight KS, Ting J, Kennedy BJ.

Dalton Trans. 2019 Apr 14;48(14):4730-4741. doi: 10.1039/c9dt00432g. Epub 2019 Mar 22.

PMID:
30901013
17.

Nilotinib-induced metabolic dysfunction: insights from a translational study using in vitro adipocyte models and patient cohorts.

Sadiq S, Owen E, Foster T, Knight K, Wang L, Pirmohamed M, Clark RE, Pushpakom S.

Leukemia. 2019 Jul;33(7):1810-1814. doi: 10.1038/s41375-018-0337-0. Epub 2019 Jan 28. No abstract available.

PMID:
30692595
18.

Dundee's Longitudinal Integrated Clerkship: drivers, implementation and early evaluation.

Bartlett M, Dowell J, Graham F, Knight K, Law S, Lockwood P, Muir F, Robson J, Watson E.

Educ Prim Care. 2019 Mar;30(2):72-79. doi: 10.1080/14739879.2018.1564889. Epub 2019 Jan 17.

PMID:
30652938
19.

Announcing the 2018 Journal of Experimental Biology Outstanding Paper Prize shortlist and winner.

Knight K.

J Exp Biol. 2019 Jan 10;222(Pt 1). pii: jeb198440. doi: 10.1242/jeb.198440. No abstract available.

20.

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.

Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R, Constine LS, Bass JK, Kuehni CE, Langer T, van Dalen EC, Bardi E, Bonne NX, Brock PR, Brooks B, Carleton B, Caron E, Chang KW, Johnston K, Knight K, Nathan PC, Orgel E, Prasad PK, Rottenberg J, Scheinemann K, de Vries ACH, Walwyn T, Weiss A, Am Zehnhoff-Dinnesen A, Cohn RJ, Landier W; International Guideline Harmonization Group ototoxicity group.

Lancet Oncol. 2019 Jan;20(1):e29-e41. doi: 10.1016/S1470-2045(18)30858-1. Review.

PMID:
30614474
21.

Everything is awesome: Don't forget the Lego.

Tagg A, Roland D, Leo GS, Knight K, Goldstein H, Davis T; Don't Forget The Bubbles.

J Paediatr Child Health. 2019 Aug;55(8):921-923. doi: 10.1111/jpc.14309. Epub 2018 Nov 22.

PMID:
30565781
22.

Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV.

Hill LM, Golin CE, Gottfredson NC, Pence BW, DiPrete B, Carda-Auten J, Groves JS, Napravnik S, Wohl D, Knight K, Flynn PM.

AIDS Behav. 2019 Aug;23(8):2037-2047. doi: 10.1007/s10461-018-2355-3.

PMID:
30535731
23.

Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care.

Cooke AC, Knight KR, Miaskowski C.

Int J Drug Policy. 2019 Jan;63:23-28. doi: 10.1016/j.drugpo.2018.09.002. Epub 2018 Nov 23.

PMID:
30472467
24.

Bacillus subtilis exopolysaccharide prevents allergic eosinophilia.

Swartzendruber JA, Incrocci RW, Wolf SA, Jung A, Knight KL.

Allergy. 2019 Apr;74(4):819-821. doi: 10.1111/all.13674. Epub 2018 Dec 10. No abstract available.

PMID:
30456900
25.

Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populations.

Hussong AM, Gottfredson NC, Bauer DJ, Curran PJ, Haroon M, Chandler R, Kahana SY, Delaney JAC, Altice FL, Beckwith CG, Feaster DJ, Flynn PM, Gordon MS, Knight K, Kuo I, Ouellet LJ, Quan VM, Seal DW, Springer SA.

Drug Alcohol Depend. 2019 Jan 1;194:59-68. doi: 10.1016/j.drugalcdep.2018.10.003. Epub 2018 Oct 23.

PMID:
30412898
26.

The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial.

Austin GM, Knight K, Bell J, Carter A, Heartin E, Watson D, Foroni L, Christmas SE, Polydoros F, Clark RE.

Br J Haematol. 2019 May;185(4):791-793. doi: 10.1111/bjh.15629. Epub 2018 Nov 8. No abstract available.

PMID:
30408160
27.
28.

Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.

Walter KR, Ford ME, Gregoski MJ, Kramer RM, Knight KD, Spruill L, Nogueira LM, Krisanits BA, Phan V, La Rue AC, Lilly MB, Ambs S, Chan K, Turner TF, Varner H, Singh S, Uribarri J, Garrett-Mayer E, Armeson KE, Hilton EJ, Clair MJ, Taylor MH, Abbott AM, Findlay VJ, Peterson LL, Magwood G, Turner DP.

Breast Cancer Res Treat. 2019 Feb;173(3):559-571. doi: 10.1007/s10549-018-4992-7. Epub 2018 Oct 27.

29.

Deformation of Transvaginal Mesh in Response to Multiaxial Loading.

Barone WR, Knight KM, Moalli PA, Abramowitch SD.

J Biomech Eng. 2019 Feb 1;141(2). doi: 10.1115/1.4041743.

PMID:
30347035
30.

Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship.

Bea VJ, Cunningham JE, Alberg AJ, Burshell D, Bauza CE, Knight KD, Hazelton TR, Varner H, Kramer R, Bolick S, Hurley D, Mosley C, Ford ME.

Front Oncol. 2018 Sep 27;8:392. doi: 10.3389/fonc.2018.00392. eCollection 2018.

31.

Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.

Friederich MW, Timal S, Powell CA, Dallabona C, Kurolap A, Palacios-Zambrano S, Bratkovic D, Derks TGJ, Bick D, Bouman K, Chatfield KC, Damouny-Naoum N, Dishop MK, Falik-Zaccai TC, Fares F, Fedida A, Ferrero I, Gallagher RC, Garesse R, Gilberti M, González C, Gowan K, Habib C, Halligan RK, Kalfon L, Knight K, Lefeber D, Mamblona L, Mandel H, Mory A, Ottoson J, Paperna T, Pruijn GJM, Rebelo-Guiomar PF, Saada A, Sainz B Jr, Salvemini H, Schoots MH, Smeitink JA, Szukszto MJ, Ter Horst HJ, van den Brandt F, van Spronsen FJ, Veltman JA, Wartchow E, Wintjes LT, Zohar Y, Fernández-Moreno MA, Baris HN, Donnini C, Minczuk M, Rodenburg RJ, Van Hove JLK.

Nat Commun. 2018 Oct 3;9(1):4065. doi: 10.1038/s41467-018-06250-w.

32.

Virtual reality distraction from painful procedures in the paediatric emergency department.

Knight K, McClenaghan CE, Singh B.

Arch Dis Child. 2019 Feb;104(2):204-205. doi: 10.1136/archdischild-2018-315921. Epub 2018 Sep 7. No abstract available.

PMID:
30194253
33.

Identification of a new European rabbit IgA with a serine-rich hinge region.

Pinheiro A, de Sousa-Pereira P, Strive T, Knight KL, Woof JM, Esteves PJ, Abrantes J.

PLoS One. 2018 Aug 8;13(8):e0201567. doi: 10.1371/journal.pone.0201567. eCollection 2018.

34.

Physical activity in the Families in Transformation (FIT) weight management program for children.

Knight KB, Devers SA, Maloney M, Bomba AK, Walker H, Tucker K, Knight SS.

Health Promot Perspect. 2018 Jul 7;8(3):237-242. doi: 10.15171/hpp.2018.32. eCollection 2018.

35.

Factors Influencing Adherence to Recommended Colorectal Cancer Surveillance: Experiences and Behaviors of Colorectal Cancer Survivors.

Ford ME, Sterba KR, Armeson K, Malek AM, Knight KD, Zapka J.

J Cancer Educ. 2018 Aug 2. doi: 10.1007/s13187-018-1398-5. [Epub ahead of print]

PMID:
30073494
36.

StaySafe: A self-administered android tablet application for helping individuals on probation make better decisions pertaining to health risk behaviors.

Lehman WEK, Pankow J, Rowan GA, Gray J, Blue TR, Muiruri R, Knight K.

Contemp Clin Trials Commun. 2018 Mar 31;10:86-93. doi: 10.1016/j.conctc.2018.03.010. eCollection 2018 Jun.

37.

Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.

Gordon SM, Stitt RS, Nee R, Bailey WT, Little DJ, Knight KR, Hughes JB, Edison JD, Olson SW.

J Rheumatol. 2019 Jan;46(1):85-92. doi: 10.3899/jrheum.171186. Epub 2018 Jul 15.

PMID:
30008456
38.

The PodPAD project: a podiatry-led integrated pathway for people with peripheral arterial disease in the UK - a pilot study.

Farndon L, Stephenson J, Binns-Hall O, Knight K, Fowler-Davis S.

J Foot Ankle Res. 2018 Jun 4;11:26. doi: 10.1186/s13047-018-0269-y. eCollection 2018.

39.

The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2018 May 22;50(5):66. doi: 10.1038/s12276-018-0094-1. Review. Erratum in: Exp Mol Med. 2019 Jul 4;51(7):71.

40.

Advancing a Model of Secondary Trauma: Consequences for Victim Service Providers.

Ellis C, Knight KE.

J Interpers Violence. 2018 May 1:886260518775161. doi: 10.1177/0886260518775161. [Epub ahead of print]

PMID:
29788814
41.

A Prospective Randomized, Double-Blind, Two-Period Crossover Pharmacokinetic Trial Comparing Green Coffee Bean Extract-A Botanically Sourced Caffeine-With a Synthetic USP Control.

Morton K, Knight K, Kalman D, Hewlings S.

Clin Pharmacol Drug Dev. 2018 Nov;7(8):871-879. doi: 10.1002/cpdd.451. Epub 2018 Apr 16.

42.

Application of modern autoradiography to nuclear forensic analysis.

Parsons-Davis T, Knight K, Fitzgerald M, Stone G, Caldeira L, Ramon C, Kristo M.

Forensic Sci Int. 2018 May;286:223-232. doi: 10.1016/j.forsciint.2018.03.027. Epub 2018 Mar 20.

PMID:
29604471
43.

Farewell Steve and welcome Pat and Katie.

Knight K.

J Exp Biol. 2018 Mar 14;221(Pt 5). pii: jeb180083. doi: 10.1242/jeb.180083. No abstract available.

44.

Development of small particle speciation for nuclear forensics by soft X-ray scanning transmission spectromicroscopy.

Pacold JI, Altman AB, Knight KB, Holliday KS, Kristo MJ, Minasian SG, Tyliszczak T, Booth CH, Shuh DK.

Analyst. 2018 Mar 12;143(6):1349-1357. doi: 10.1039/c7an01838j.

45.

Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines.

Raikar SS, Fleischer LC, Moot R, Fedanov A, Paik NY, Knight KA, Doering CB, Spencer HT.

Oncoimmunology. 2017 Dec 26;7(3):e1407898. doi: 10.1080/2162402X.2017.1407898. eCollection 2018.

46.

De novo mutations in GRIN1 cause extensive bilateral polymicrogyria.

Fry AE, Fawcett KA, Zelnik N, Yuan H, Thompson BAN, Shemer-Meiri L, Cushion TD, Mugalaasi H, Sims D, Stoodley N, Chung SK, Rees MI, Patel CV, Brueton LA, Layet V, Giuliano F, Kerr MP, Banne E, Meiner V, Lerman-Sagie T, Helbig KL, Kofman LH, Knight KM, Chen W, Kannan V, Hu C, Kusumoto H, Zhang J, Swanger SA, Shaulsky GH, Mirzaa GM, Muir AM, Mefford HC, Dobyns WB, Mackenzie AB, Mullins JGL, Lemke JR, Bahi-Buisson N, Traynelis SF, Iago HF, Pilz DT.

Brain. 2018 Mar 1;141(3):698-712. doi: 10.1093/brain/awx358.

47.

Preventing Mesh Pore Collapse by Designing Mesh Pores With Auxetic Geometries: A Comprehensive Evaluation Via Computational Modeling.

Knight KM, Moalli PA, Abramowitch SD.

J Biomech Eng. 2018 May 1;140(5). doi: 10.1115/1.4039058.

PMID:
29350744
48.

Testing a chemical series inspired by plant stress oxylipin signalling agents for herbicide safening activity.

Brazier-Hicks M, Knight KM, Sellars JD, Steel PG, Edwards R.

Pest Manag Sci. 2018 Apr;74(4):828-836. doi: 10.1002/ps.4859. Epub 2018 Feb 6.

49.

The 2017 Journal of Experimental Biology Outstanding Paper Prize shortlist and winner.

Knight K.

J Exp Biol. 2018 Jan 9;221(Pt 1). pii: jeb175208. doi: 10.1242/jeb.175208. No abstract available.

50.

Long-Term Variability of Distortion-Product Otoacoustic Emissions in Infants and Children and Its Relation to Pediatric Ototoxicity Monitoring.

Konrad-Martin D, Knight K, McMillan GP, Dreisbach LE, Nelson E, Dille M.

Ear Hear. 2017 Dec 26. doi: 10.1097/AUD.0000000000000536. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center